
CLINICAL NEXT GENERATION SEQUENCING REVEALS AN
H3F3A GENE AS A NEW POTENTIAL GENE CANDIDATE
FOR MICROCEPHALY ASSOCIATED WITH SEVERE
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY
AND GROWTH RETARDATION Maver A1, Čuturilo G2,3, Ruml Stojanović J3, Peterlin B1,* *Corresponding Author: Professor Borut Peterlin, Clinical Institute of Genomic Medicine, University
Medical Center Ljubljana, Šlajmerjeva 4, 1000 Ljubljana, Slovenia. Tel: +38615401137. E-mail:
borut.peterlin@kclj.si page: 65
|
DISCUSSION
We report the H3F3A gene as a new candidate gene,
associated with microcephaly, severe global developmental
delay and intellectual disability. Additionally, prenatal
and postnatal growth retardation, structural abnormalities
of central nervous system and dysmorphological features
were present in the reported patient.
The H3F3A gene, together with the H3F3B gene,
codes the replacement histone H3.3. The H3.3-containing
nucleosomes remain highly dynamic and are involved in the
control of neuronal- and glial-specific gene expression patterns
throughout life, which are required to support synaptic
connectivity and behavioral plasticity [14]. H3.3 knock
down resulted in decreased numbers of dendritic spines on
pyramidal cells and global reduction of both excitatory and
inhibitory synapses in the mouse model [14]. Disruption
of the H3F3A gene in transgenic mice resulted in stunted
growth and neuromuscular deficits [15]. Somatic mutations
in the H3F3 gene were reported in pediatric glioblastoma
[16] and in giant cell tumors of the bone [17]. Furthermore,
it was recently suggested that the pathogenic mechanism
of germline histone mutations is distinct from that of the
published cancer-associated somatic histone mutations, and
may converge on control of cell proliferation [18].
In our patient, we identified a heterozygous de novo
missense variant in the H3F3A gene (NM_002107.4: c.185
T>G), which is absent from the gnomAD and from the
Slovenian Genome databases. The identified variant affects
a highly conserved leucine residue at position 62 of the
Histone H3 protein and is predicted to affect the physicochemical
properties of the affected protein domain.
Further evidence for the potential role of the H3F3A
gene in neurodevelopment is also based on the ClinVar
reports of two patients with likely pathogenic heterozygous missense mutations in the H3F3A gene, c.377A>G (p.Gln
126Arg), who both demonstrated a neurological phenotype
including hypotonia, global developmental delay, intellectual
disability, visual impairment and dysmorphic features
(ClinVar accession: VCV000520774.1) [13].
The limitation of our case report is lack of functional
studies and lack of additional patients with mutations in
the H3F3A gene and the suggested phenotype. Nevertheless,
we provide evidence on a potentially new mechanism
involving histones in the regulation of gene expression in
the brain as the cause of a syndromic microcephaly.
Declaration of Interest. The authors report no conflicts
of interest. The authors alone are responsible for the
content and writing of this article.
Funding. This study was supported by the funding of
Slovenian Research agency projects J3-8205 and J3-9280
and the framework programme P3-0326.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|